Lyocentre

Biose Industrie, formerly known as Laboratoires Lyocentre, is a prominent French pharmaceutical company and a global leader in the development and manufacturing of Live Biotherapeutic Products (LBPs). Founded in 1951 and headquartered in Aurillac, the company specializes in microbiome-based therapies with a strong historical focus on gynecology and gastroenterology. Biose Industrie operates as a specialized CDMO, offering end-to-end services from strain development and fermentation to clinical and commercial-scale production. Their expertise covers a wide range of microbial strains, including bacteria and yeast, processed under strict GMP standards. The company is well-known for its proprietary product Gynophilus, which is used to treat vaginal dysbiosis. Today, Biose Industrie supports biotech and pharma partners worldwide in bringing innovative microbiome-derived medicines to market.